A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
Hu14.18K322A联合诱导化疗治疗新诊断高危神经母细胞瘤患儿的II期临床试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-1452
Furman, Wayne L; Federico, Sara M; McCarville, Mary Beth; Shulkin, Barry L; Davidoff, Andrew M; Krasin, Matthew J; Sahr, Natasha; Sykes, April; Wu, Jianrong; Brennan, Rachel C; Bishop, Michael William; Helmig, Sara; Stewart, Elizabeth; Navid, Fariba; Triplett, Brandon; Santana, Victor M; Bahrami, Armita; Anthony, Gwendolyn; Yu, Alice L; Hank, Jacquelyn; Gillies, Stephen D; Sondel, Paul M; Leung, Wing H; Pappo, Alberto S